Plasma Macrophage Migration Inhibitory Factor Concentration at Each Spectrum of Tuberculosis
- 1 February 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 43 (2), 98-103
- https://doi.org/10.1089/jir.2022.0197
Abstract
Macrophage migration inhibitory factor (MIF) is an inflammatory mediator in several diseases, including tuberculosis (TB). However, the role of MIF in each stage of TB remains to be further elucidated. Thus, this study aimed to analyze the differences in plasma MIF protein levels in patients with active pulmonary TB, positive and negative interferon-gamma release assay (IGRA) household contacts (HHCs), and healthy controls (HCs). Plasma MIF concentration was significantly higher in patients with active–new pulmonary tuberculosis (ATB) and HHCs compared with HCs (mean ± standard deviation: 17.32 ± 16.85, 16.29 ± 14.21, and 7.29 ± 5.39 ng/mL, respectively; P = 0.002). The plasma MIF concentration was not statistically different when compared between patients with ATB, IGRA-positive HHCs (17.44 ± 16.6 ng/mL), and IGRA-negative HHCs (14.34 ± 8.7 ng/mL) (P = 0.897). In conclusion, ATB patients, IGRA-positive HHCs, and IGRA-negative HHCs have a higher MIF concentration than HCs. This shows the involvement of MIF in each stage of TB, starting from TB exposure and infection, but not symptomatic, to the active stage.Keywords
This publication has 26 references indexed in Scilit:
- Single nucleotide polymorphisms in cytokine MIF gene promoter region are closely associated with human susceptibility to tuberculosis in a southwestern province of ChinaInfection, Genetics and Evolution, 2016
- Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosisInfectious Diseases, 2015
- Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group StudyAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Macrophage defense mechanisms against intracellular bacteriaImmunological Reviews, 2015
- Early clearance of Mycobacterium tuberculosis: a new frontier in preventionImmunology, 2013
- Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosisProceedings of the National Academy of Sciences of the United States of America, 2013
- Study of the relationship between human MIF level, MIF-794CATT5-8 microsatellite polymorphism, and susceptibility of tuberculosis in Southwest ChinaThe Brazilian Journal of Infectious Diseases, 2012
- Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing TuberculosisPLOS ONE, 2012
- Macrophage Migration Inhibitory Factor: A Multifunctional Cytokine in Rheumatic DiseasesArthritis, 2010
- Apoptotic Neutrophils Release Macrophage Migration Inhibitory Factor upon Stimulation with Tumor Necrosis Factor-αOnline Journal of Public Health Informatics, 2006